Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

genus pharmaceuticals ltd - ethambutol hydrochloride; pyrazinamide; isoniazid; rifampicin - oral tablet - 275mg ; 400mg ; 75mg ; 150mg

Europos Sąjunga - anglų - EMA (European Medicines Agency)

rad neurim pharmaceuticals eec sarl - melatonin - sleep initiation and maintenance disorders; autistic disorder - psycholeptics - slenyto is indicated for the treatment of insomnia in children and adolescents aged 2-18 with autism spectrum disorder (asd) and / or smith-magenis syndrome, where sleep hygiene measures have been insufficient.

Airija - anglų - HPRA (Health Products Regulatory Authority)

pharma nord aps - melatonin - film-coated tablet - 3 milligram(s) - melatonin

Izraelis - anglų - Ministry of Health

neurim pharmaceuticals (1991) ltd, israel - melatonin - tablets prolonged release - melatonin 2 mg - melatonin - short-term treatment for primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

rad data australia pty ltd - melatonin, quantity: 5 mg - tablet, modified release - excipient ingredients: ammonio methacrylate copolymer; calcium hydrogen phosphate dihydrate; lactose monohydrate; colloidal anhydrous silica; magnesium stearate; titanium dioxide; glucose monohydrate; maltodextrin; iron oxide yellow; lecithin; carmellose sodium - slenyto is indicated for the treatment of insomnia in children and adolescents aged 2-18 with autism spectrum disorder (asd) and / or smith-magenis syndrome, where sleep hygiene measures have been insufficient.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

rad data australia pty ltd - melatonin, quantity: 1 mg - tablet, modified release - excipient ingredients: ammonio methacrylate copolymer; calcium hydrogen phosphate dihydrate; lactose monohydrate; colloidal anhydrous silica; purified talc; magnesium stearate; titanium dioxide; glucose monohydrate; maltodextrin; iron oxide yellow; iron oxide red; lecithin; carmellose sodium - slenyto is indicated for the treatment of insomnia in children and adolescents aged 2-18 with autism spectrum disorder (asd) and / or smith-magenis syndrome, where sleep hygiene measures have been insufficient.

Airija - anglų - HPRA (Health Products Regulatory Authority)

clinigen healthcare b.v. - melatonin - oral solution - melatonin

Europos Sąjunga - anglų - EMA (European Medicines Agency)

rad neurim pharmaceuticals eec sarl - melatonin - sleep initiation and maintenance disorders - psycholeptics - melatonin neurim is indicated as monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over.

Malta - anglų - Medicines Authority

przedsiebiorstwo farmaceutyczne lek-am sp. z o.o 14a ostrzykowizna street, 05-170 zakroczym, , poland - prolonged-release tablet - melatonin 2 mg - psycholeptics

Malta - anglų - Medicines Authority

przedsiebiorstwo farmaceutyczne lek-am sp. z o.o 14a ostrzykowizna street, 05-170 zakroczym, , poland - prolonged-release tablet - melatonin 2 mg - psycholeptics